Now Available: Innovation in Quantitative Medicine Summit Event Summary

https://healthpolicy.duke.edu/sites/default/files/2026-10/Summary%20Innovation%20in%20QM%20Summit.pdf?utm_medium=email&utm_source=govdelivery In September 2026, the FDA Quantitative Medicine Center of Excellence, in collaboration with the Duke-Margolis Institute for Health Policy, hosted the “Innovation in Quantitative Medicine Summit” virtual public meeting to bring together regulators, researchers, and industry representatives to discuss where quantitative medicine approaches have the potential to transform drug development or clinical practice as well as related challenges and use cases. Summit participants highlighted opportunities for the upcoming Quantitative Medicine Innovation Network to advance individualized therapies, strengthen early clinical development decision making, and promote sharing of diverse data. For more details about the workshop, read the event summary. https://www.federalregister.gov/documents/2026/08/05/2026-15887/establishment-of-a-quantitative-medicine-innovation-network-scope-feasibility-and-opportunities?utm_medium=email&utm_source=govdelivery